(Q34411773)

2 August 2017

1 reference

title

Molecular pharmacology of topiramate: managing seizures and preventing migraine (English)

1 reference

2 August 2017

1 reference

1 reference

H Steve White

1

1 reference

2 August 2017

publication date

1 April 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

45 Suppl 1

1 reference

2 August 2017

page(s)

S48-56

1 reference

The process of epileptogenesis: a pathophysiological approach.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Sensitization of meningeal sensory neurons and the origin of headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Migraine--current understanding and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Therapeutic implications of central and peripheral neurologic mechanisms in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal–astroglial cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Modulation by topiramate of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Topiramate alters excitatory synaptic transmission in mouse hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Effects of CO2 on excitatory transmission apparently caused by changes in intracellular pH in the rat hippocampal slice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

The pharmacology of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2005.4501006.X

10.1111/J.1526-4610.2005.4501006.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference